As the markets digest news of the Fed's reduction of its huge balance sheet, several stocks are piquing investor interest in pre-market.
Hermann Miller Inc (NASDAQ:MLHR), the manufacturer of office furniture, lost 2.72% to US$34 after the bell following in-line first quarter earnings, but with sales exceeding Wall Street estimates.
Wall Street expects the club to report quarterly earnings at US$7.88 per share on revenue of US$205.85mln.
Shares in Abiomed Inc (NASDAQ:ABMD) added 2.91% to stand at US$163 after the bell and are expected to gain again today after it announced the key FDA pre-market approval for the Impella RP heart pump.
In a similar vein, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) gained almost 3% post-bell after it reported the FDA approval for Sodium Bicarbonate injection.